Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer

Published:2014-08 Issue:8 Volume:25 Page:1578-1584
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mok T.S.,Geater S.L.,Iannotti N.,Thongprasert S.,Spira A.,Smith D.,Lee V.,Lim W.T.,Reyderman L.,Wang B.,Gopalakrishna P.,Garzon F.,Xu L.,Reynolds C.

Funder

Eisai Ltd

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/8/1578/16703335/mdu174.pdf

Reference24 articles.

1. J Ferlay HR Shin F Bray. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. http://globocan.iarc.fr (11 December 2012, date last accessed).

2. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

3. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004

4. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

5. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The proportion of randomized controlled trials that inform clinical practice;eLife;2022-08-17

2. CT Combined with Multiparameter MRI in Differentiating Pathological Subtypes of Non-Small-Cell Lung Cancer before Surgery;Contrast Media & Molecular Imaging;2022-05-17

3. Eribulin improves tumor oxygenation demonstrated by 18F-DiFA hypoxia imaging, leading to radio-sensitization in human cancer xenograft models;European Journal of Nuclear Medicine and Molecular Imaging;2021-09-01

4. Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds;Expert Opinion on Investigational Drugs;2019-06-03

5. A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung cancer;Annals of Oncology;2017-09